{"id":"3cf52c95-d578-4c3c-ad48-9b19ff63a715","kind":"news","code":"3cf52c95-d578-4c3c-ad48-9b19ff63a715","name":"Xunming Shengke raises USD 100 million in Series B funding, bringing total funding close to USD 200 million","nameBasis":"translated-title","summary":"On 2026/8/11, Elsewhere reported that Chinese biological AI company Xunming Shengke raised USD 100 million in Series B funding, bringing total funding close to USD 200 million. The round was completed in stages, with proceeds supporting biological foundation model R&D and training at scale.","description":"","country":null,"category":null,"originalName":"寻明生科完成1亿美元B轮融资，累计融资近2亿美元","eventDate":"2026-08-11T00:00:00.000Z","website":"https://elsewhere.news/zh/5ycapital/1bai-5y-news","sourceUpdatedAt":"2026-10-20T04:04:20.832Z","englishUpdatedAt":"2026-10-20T18:31:08.162Z","reviewedAt":"2026-10-20T18:31:08.162Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"41731cd43e2cabfd009fd98bdbd92e611841cc27546f22b5f7a0052f9ac5afaf","companyId":"45d3d734-4612-4acd-93a4-8687ab7e94ca","foundedYear":null,"logoUrl":null,"originalText":"2026年8月11日，据Elsewhere报道，中国生物AI公司寻明生科完成1亿美元B轮融资，累计融资近2亿美元；本轮分阶段完成，资金将用于生物基座模型研发与规模化训练。","sources":[{"url":"https://elsewhere.news/zh/5ycapital/1bai-5y-news","publishedOn":"2026-08-11T00:00:00.000Z"}],"related":[{"id":"45d3d734-4612-4acd-93a4-8687ab7e94ca","kind":"companies","code":"UB-C5576","name":"Aureka Biotechnologies","nameBasis":"source-english","summary":"Antibody drug discovery driven by generative AI and digital biology","description":"","country":null,"category":null,"originalName":"Aureka Biotechnologies","eventDate":null,"website":"https://www.aurekabio.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:23:30.014Z","reviewedAt":"2026-10-20T18:23:30.014Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"3bd42e5b778768ce4e8c1f0761b984ee7ceb9b5700c511566f259d9de0713575","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/aureka-biotechnologies"},{"id":"da8ff968-58e4-459a-a4ea-5c1dfdef62e8","kind":"institutions","code":"UB-I254","name":"Granite Asia","nameBasis":"original-brand","summary":"An Asian private equity investment firm focused on growth and acquisition investments.","description":"An Asian private equity investment firm focused on growth and acquisition investments.","country":"Hong Kong, China","category":null,"originalName":"Granite Asia","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:15.838Z","englishUpdatedAt":"2026-10-20T18:27:03.788Z","reviewedAt":"2026-10-20T18:27:03.788Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"471e515eea3ae3b3f7084ae5e68efc714c944bc4112ecb175f09c6e38e6d22c9","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/granite-asia"},{"id":"67e42b1e-f516-42b6-b582-0baea3db0b3c","kind":"institutions","code":"UB-I569","name":"Honghui Fund","nameBasis":"transliterated","summary":"A Chinese healthcare private equity firm.","description":"A Chinese healthcare private equity firm.","country":null,"category":null,"originalName":"弘晖基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:25.567Z","englishUpdatedAt":"2026-10-15T18:21:17.103Z","reviewedAt":"2026-10-15T18:21:17.103Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"33dbc839341b04ebb741e0baf486a4cb25c9b64bcee3250bdab33579f97b7c06","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/honghui-fund"},{"id":"9479d7c1-e67a-44d8-8e1e-7c02c9d1af7d","kind":"institutions","code":"UB-I209","name":"Jingwei Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","description":"A prominent Chinese early-stage venture capital firm, formerly Matrix Partners China, focused on early-stage technology, consumer, healthcare, and other investments.","country":null,"category":null,"originalName":"经纬创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.457Z","englishUpdatedAt":"2026-10-15T21:39:21.207Z","reviewedAt":"2026-10-15T21:39:21.207Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fc153d78fb297c01b8830bd5dec0843514a8205f64f028c590a92825203f7cc4","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/jingwei-venture-capital"},{"id":"c7b087a5-ed8c-4bc9-92dc-edade94beb0b","kind":"institutions","code":"UB-I570","name":"Niuerli Capital","nameBasis":"transliterated","summary":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","description":"Niuerli Capital is a domestic Chinese early-stage venture capital firm, specializing in startup teams and early-stage companies.","country":null,"category":null,"originalName":"纽尔利资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:26.013Z","englishUpdatedAt":"2026-10-15T18:43:03.796Z","reviewedAt":"2026-10-15T18:43:03.796Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20eec776f98123320e240f6d1c63ee5204b7eb8d87f0bb01357cfcd4cd70bae5","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/niuerli-capital"},{"id":"53b8bbea-57c1-4fc4-aa07-170e7dc156e4","kind":"institutions","code":"UB-I235","name":"Qiming Venture Capital","nameBasis":"transliterated","summary":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","description":"A prominent Chinese venture capital firm focused on early- and growth-stage healthcare, technology, and consumer investments.","country":null,"category":null,"originalName":"启明创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:21.507Z","englishUpdatedAt":"2026-10-15T21:37:02.669Z","reviewedAt":"2026-10-15T21:37:02.669Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"91416aa941c85812e1db97ffa3575271ef78edc44c579f705171db1c1638f73d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qiming-venture-capital"}],"path":"/news/3cf52c95-d578-4c3c-ad48-9b19ff63a715","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Aureka Biotechnologies","path":"/companies/aureka-biotechnologies"}},"canonical":"https://uniquebase.ai/news/3cf52c95-d578-4c3c-ad48-9b19ff63a715"}